重症监护
止血的管理和优化
抗纤溶药物
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. （打开新窗口）
来源: Lancet 2019;394(10210):1713-23.
检索: PubMed 31623894
DOI码: 10.1016/S0140-6736(19)32233-0
Alternatives to allogeneic platelet transfusion. （打开新窗口）
来源: Br J Haematol 2016;175(3):381-92.
检索: PubMed 27650431
DOI码: 10.1111/bjh.14338
Tranexamic acid: less bleeding and less thrombosis? （打开新窗口）
来源: Crit Care 2012;16(3):135.
检索: PubMed 22748073
DOI码: 10.1186/cc11374
Tranexamic acid for reducing mortality in emergency and urgent surgery. （打开新窗口）
来源: Cochrane Database Syst Rev 2013;(1):CD010245.
检索: PubMed 23440847
DOI码: 10.1002/14651858.CD010245.pub2
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. （打开新窗口）
来源: Lancet 2011;377(9771):1096-101, 1101.e1-2.
检索: PubMed 21439633
DOI码: 10.1016/S0140-6736(11)60278-X
Antifibrinolytic drugs for acute traumatic injury. （打开新窗口）
来源: Cochrane Database Syst Rev 2011;(1):CD004896.
检索: PubMed 21249666
DOI码: 10.1002/14651858.CD004896.pub3
Use of tranexamic acid to reduce bleeding in burns surgery. （打开新窗口）
来源: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.
检索: PubMed 21983540
DOI码: 10.1016/j.bjps.2011.09.028
Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. （打开新窗口）
来源: Burns. 2022;48(3):522-28.
检索: PubMed 35339324
DOI码: 10.1016/j.burns.2022.03.002
重组活化凝血因子VII（rFVIIa）
Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. （打开新窗口）
来源: J Blood Med 2011;2:131-4.
检索: PubMed 22287872
DOI码: 10.2147/JBM.S21609
The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. （打开新窗口）
来源: Transfusion 2009;49 Suppl 5:240S-7S.
检索: PubMed 19954486
DOI码: 10.1111/j.1537-2995.2008.01987.x
The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. （打开新窗口）
来源: Transfusion 2013;53 Suppl 1:91S-5S.
检索: PubMed 23301979
DOI码: 10.1111/trf.12041
A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. （打开新窗口）
来源: Am Surg 2005;71(5):414-5.
检索: PubMed 15986972
Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. （打开新窗口）
来源: J Trauma 2010;69(3):489-500.
检索: PubMed 20838118
DOI码: 10.1097/TA.0b013e3181edf36e
Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. （打开新窗口）
来源: Ann Surg 2008;248(1):61-8.
检索: PubMed 18580208
DOI码: 10.1097/SLA.0b013e318176c4ec
Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. （打开新窗口）
来源: J Trauma 2006;61(4):1016-8.
检索: PubMed 17033583
DOI码: 10.1097/01.ta.0000239261.48022.f1
Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. （打开新窗口）
来源: ANZ J Surg 2013;83(3):155-60.
检索: PubMed 23035873
DOI码: 10.1111/j.1445-2197.2012.06285.x
Recombinant factor VIIa in trauma patients with the 'triad of death.' （打开新窗口）
来源: Injury 2012;43(9):1409-14.
检索: PubMed 21345431
DOI码: 10.1016/j.injury.2011.01.033
Low-dose recombinant factor VIIa for trauma patients with coagulopathy. （打开新窗口）
来源: Injury 2008;39(9):1054-61.
检索: PubMed 18656871
DOI码: 10.1016/j.injury.2008.03.032
Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). （打开新窗口）
来源: Anesthesiology 2003;98(6):1513-5.
检索: PubMed 12766668
凝血因子浓缩剂
Alternatives to allogeneic platelet transfusion. （打开新窗口）
来源: Br J Haematol 2016;175(3):381-92.
检索: PubMed 27650431
DOI码: 10.1111/bjh.14338
The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. （打开新窗口）
来源: Transfusion 2013;53 Suppl 1:91S-5S.
检索: PubMed 23301979
DOI码: 10.1111/trf.12041
Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. （打开新窗口）
来源: Thromb Res 2014;134(2):360-8.
检索: PubMed 24857189
DOI码: 10.1016/j.thromres.2014.05.008
Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. （打开新窗口）
来源: Br J Haematol 2013;160(2):228-36.
检索: PubMed 23151086
DOI码: 10.1111/bjh.12118
Strategies to reduce the use of blood products: a European perspective. （打开新窗口）
来源: Curr Opin Anaesthesiol 2012;25(1):59-65.
检索: PubMed 22113184
DOI码: 10.1097/ACO.0b013e32834dec98
去氨加压素
Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. （打开新窗口）
来源: Anesthesiology 2008;109(6):1063-76.
检索: PubMed 19034103
DOI码: 10.1097/ALN.0b013e31818db18b
Alternatives to allogeneic platelet transfusion. （打开新窗口）
来源: Br J Haematol 2016;175(3):381-92.
检索: PubMed 27650431
DOI码: 10.1111/bjh.14338
Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. （打开新窗口）
来源: Blood Rev 2014;28(3):95-102.
检索: PubMed 24703870
DOI码: 10.1016/j.blre.2014.03.001
其他制剂
Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. （打开新窗口）
来源: JAMA 1987;258(14):1916-9.
检索: PubMed 3656602
DOI码: 10.1001/jama.1987.03400140078028
Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. （打开新窗口）
来源: Blood Coagul Fibrinolysis 2002;13(1):49-52.
检索: PubMed 11994567
DOI码: 10.1097/00001721-200201000-00007
局部止血药
The use of fibrin sealant in burn operations. （打开新窗口）
来源: Surgery 2007;142(4 Suppl):S50-4.
检索: PubMed 18019939
DOI码: 10.1016/j.surg.2007.06.026
Use of fibrin sealant in thermal injury. （打开新窗口）
来源: J Burn Care Rehabil 1997;18(5):429-34.
检索: PubMed 9313125
DOI码: 10.1097/00004630-199709000-00011
利用血液粘弹性检测辨别外科性出血或凝血病出血
Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. （打开新窗口）
来源: Br J Anaesth 2012;109(3):376-81.
检索: PubMed 22719014
DOI码: 10.1093/bja/aes186
Transfusion in trauma: why and how should we change our current practice? （打开新窗口）
来源: Curr Opin Anaesthesiol 2009;22(2):305-12.
检索: PubMed 19390257
DOI码: 10.1097/ACO.0b013e3283212c7c
Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. （打开新窗口）
来源: Health Technol Assess 2015;19(58):1-228.
检索: PubMed 26215747
DOI码: 10.3310/hta19580